3 completed. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow Risk Reduction: new trials by email Literature Review of Risk Reduction trials Research Report on Risk Reduction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Salmonella Conjugates CVD 2000: Study of Responses to Vaccination With Trivalent Salmonella Conjugate Vaccine to Prevent Invasive Salmonella Disease Trivalent Salmonella Conjugate Vaccine (TSCV) Full-Strength Formulation, Trivalent Salmonella Conjugate Vaccine (TSCV) Half-Strength Formulation, Trivalent Salmonella Conjugate Vaccine (TSCV) Dilutional Half-Strength Formulation - Risk Reduction | Phase 1 | Completed | University of Maryland, Baltimore | 82 | 2022-08-15 | 2023-09-21 |
| Salmonella Conjugates CVD 1000: Study of Responses to Vaccination With Trivalent Invasive Salmonella Disease Vaccine Trivalent Invasive Salmonella Disease Vaccine (6.25 µg), Trivalent Invasive Salmonella Disease Vaccine (12 µg), Trivalent Invasive Salmonella Disease Vaccine (25 µg) - Risk Reduction | Phase 1 | Completed | University of Maryland, Baltimore | 96 | 2019-10-28 | 2025-03-11 |
| Project Power: An HIV Risk Reduction Intervention for Black Men Who Have Sex With Men and Women (BMSM/W) PROJECT POWER, Power Health - Unsafe Sex, Risk Reduction | Phase 1 / Phase 2 | Completed | Nova Southeastern University | 211 | 2011-07-01 | 2014-03-11 |
Risk Reduction Behavior (3) · Unsafe Sex (1)
Behavior (3) · Sexual Behavior (1)
University of Maryland, Baltimore (2) · Nova Southeastern University (1)
United States (3)